Pharmacogenomical study on β2AR-responsiveness

DNA and neutrophils were isolated from blood samples of 60 volunteers. Sequencing of the complete receptor gene allowed analysis for receptor polymorphisms (SNP). An ex-vivo assay on neutrophils was used for characterization of the volunteer’s individual responsiveness to β2AR-drugs (broncho-dilative component in asthma spray). Responsiveness was decreased for carriers of Gly16Arg SNP.